Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylsalicylic acid add-on therapy in COPD II–III
2010-022123-29Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing ASA add-on therapy with Placebo add-on (2 arms). Primary endpoint: Change in FEV1 at 12 weeks vs baseline. Started Nov 2010; status: terminated.
02
Drugs
aspirin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-022123-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022123-29.